J. Wendy Kim's most recent trade in BioVie Inc was a trade of 110,100 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 110,100 | 110,100 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 14,417 | 14,417 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Kim Wendy Joanne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 5,000 | 44,148 (0%) | 0% | 0 | Common Stock | |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 73,000 | 112,196 (2%) | 1% | 0 | Common Stock | |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 16 Feb 2023 | 18,250 | 93,940 (1%) | 0% | 0.5 | 8,651 | Common Stock |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.12 per share. | 16 Feb 2023 | 2,476 | 39,148 (0%) | 0% | 6.1 | 15,153 | COMMON STOCK |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.51 per share. | 16 Feb 2023 | 2,476 | 41,672 (0%) | 0% | 5.5 | 13,643 | Common Stock |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 16 Feb 2023 | 2,476 | 39,196 (0%) | 0% | 1.2 | 2,922 | Common Stock |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 39,624 | 41,624 (0%) | 0% | 0 | COMMON STOCK | |
| BioVie Inc | Joanne Wendy Kim | CFO | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 07 Dec 2021 | 2,000 | 2,000 (0%) | 0% | 5.4 | 10,798 | Class A common stock, par value $0.0001 |
| BioVie Inc | Joanne Wendy Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 124,167 | 124,167 | - | - | Stock Option (right to buy) |